FEATURED ARTICLES
Designing Trials For Disease Modification: Cereno Scientific's Approach To Pulmonary Arterial Hypertension
Cereno Scientific’s Rahul Agrawal discusses the scientific and strategic rationale behind extending the company’s Phase 2b study duration and how the company incorporated regulator and patient input.
-
![Tidioute Health Care Center-GettyImages-1273786594]( "Expanding Access To Cell Therapy Trials Beyond AMCs And Into The Community")
Expanding Access To Cell Therapy Trials Beyond AMCs And Into The CommunityCEO Paul J. Hastings discusses Nkarta's decision to bring outpatient dosing into the community setting, including how it communicated with the FDA on safety and how the changes will improve patient access.
-
![Genetic engineering, GMO and Gene manipulation-GettyImages-1344879684]( "Why Cell And Gene Therapy Has Not Reached More Patients — And Why Clinical Operations Is The Bridge")
-
![Female doctor examining patient-GettyImages-2217109316]( "Safety Is The Mantra In Kivu Bioscience's ADC Trials For Solid Tumors")
Safety Is The Mantra In Kivu Bioscience's ADC Trials For Solid TumorsKivu Bioscience CEO Mohit Trikha, Ph.D., contends that safer ADCs enable higher effective dosing and could elicit a better response in solid tumors. In this Q&A, he also discusses how parallel trial execution, global site strategy, and stakeholder collaboration support rapid, data-driven development.
SERVICES & PRODUCTS
Design, build, simulate, and analyze clinical studies in one connected system. Embedded intelligence supports the full lifecycle, from protocol development to closeout.
At DVCR, our Central Laboratory Services are built for multi-site studies, combining customizable kits, next-day results and real-time shipment monitoring to keep every site aligned and on schedule. Backed by dedicated client teams, a comprehensive Central Lab Manual and rapid-response testing, we deliver the flexibility and speed your studies require.
Your trusted partner for decentralized post-marketing surveillance clinical trials and real-world evidence collection. Point-of-need accessibility. Proven compliance.
Why Work With AutoCruitment?
AutoCruitment is the ultimate patient recruitment solution for clinical trials. We specialize in identifying, enrolling, and supporting the most qualified patients for clinical trials through a sophisticated screening process that aligns directly with your study’s protocols.
At Endpoint Clinical, our solutions proactively problem-solve. We expect the unexpected, so you can focus on reaching key clinical trial milestones.
Your trusted RTSM solution, PULSE is designed to support all study designs with configurable, pre-validated components. PULSE empowers study teams to easily manage randomization and trial supply workflows with flexibility and precision.